Ticagrelor versus clopidogrel in the management of acute myocardial infarction
Hypothesis: In the care of acute myocardial infarction, ticagrelor attenuates post-ischemic myocardial damage and inhibits platelet activity to a greater extent than clopidogrel. Methods: Scholarly articles published in the last 10 years were compiled from a PubMed MeSH search focusing on acute coro...
Saved in:
Main Authors: | Candice Volney (Author), Anthony Collins (Author), Sarah Adams (Author) |
---|---|
Format: | Book |
Published: |
Greater Baltimore Medical Center,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023) -
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
by: Grima DT, et al.
Published: (2014) -
Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
by: Peixun He, et al.
Published: (2021) -
Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain
by: E. Molina-Cuadrado, et al.
Published: (2014) -
Comparison of Ticagrelor with Clopidogrel in Reducing Interleukin-17 and Myeloperoxidase Expression in Thrombus and Improving Postprocedural Coronary Flow in ST-segment Elevation Myocardial Infarction Patients
by: WenHua Li, et al.
Published: (2018)